Readability of Over-the-Counter Medication Labels

This study evaluated information on over-the-counter (OTC) medication labels. Brand-name OTC products were examined to determine compliance with the Label Readability Guidelines recommended by the Nonprescription Drug Manufacturers Association (NOMA). Additionally, the use of pictures on OTC medicat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Pharmaceutical Association (1996) 1997-09, Vol.37 (5), p.522-528
Hauptverfasser: Sansgiry, Sujit S., Cady, Paul S., Patil, Shubhada
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 528
container_issue 5
container_start_page 522
container_title Journal of the American Pharmaceutical Association (1996)
container_volume 37
creator Sansgiry, Sujit S.
Cady, Paul S.
Patil, Shubhada
description This study evaluated information on over-the-counter (OTC) medication labels. Brand-name OTC products were examined to determine compliance with the Label Readability Guidelines recommended by the Nonprescription Drug Manufacturers Association (NOMA). Additionally, the use of pictures on OTC medication labels was assessed. The effect of pictures on other aspects of label design that may affect comprehension was also evaluated. We evaluated 100 OTC medication labels (20 analgesics and 80 cold/cough products). Assessment of label content was based on certain aspects of label design, such as package size, font size of written information, format of information on warnings and indications, use of pictures, and use of advertising claims on product labels. Many products evaluated did not meet NOMA guidelines. Even when font size of product name increased with increase in package size, font size on warnings and indications remained constant at 6 points. Lack of boldface (63%), use of all uppercase font (30%), use of hyphenation (49%), lack of paragraph breaks (19%), and the small font size of 6 points or less (98%) could reduce readability. Packages containing pictures were significantly larger than packages without pictures. Several packages (30%) contained pictures in the indications section. Many products contained advertising claims that were classified as "green" or "quality" (41%) and "free" (38%). Additionally, 43 different advertising claims were identified; some of these may be difficult for patients to interpret. The findings may help FDA develop specific regulations to improve label readability. Pharmacists who recommend OTC products to consumers should be aware of these issues and evaluate requests by consumers regarding OTC drugs accordingly. Acknowledgments: This research was partially supported by the Department of Pharmacy Practice and Administrative Sciences, and by a grant from the Graduate Students Research Committee, Idaho State University.
doi_str_mv 10.1016/S1086-5802(16)30244-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79565884</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1086580216302443</els_id><sourcerecordid>79565884</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2073-e89c2921d1a74ff723a5d1d962dace550a31f215fd1f9558700077004a069a23</originalsourceid><addsrcrecordid>eNqFkE1PwzAMhnMAjTH4CZN6QnAoOEnTNieEKr6koUmwe5Qljgjq2pG0k_bv6T60Kxdbtt_Xlh9CphTuKdD84YtCmaeiBHZL8zsOLMtSfkbGp_YFuYzxB4ALysoRGcmskBnwMaGfqK1e-tp326R1yXyDIe2-Ma3avukwJB9ovdGdb5tkppdYxyty7nQd8fqYJ2Tx8ryo3tLZ_PW9epqlhkHBUyylYZJRS3WROVcwroWlVubMaoNCgObUMSqcpU4KURYAUAwh05BLzfiE3BzWrkP722Ps1MpHg3WtG2z7qAopclGW2SAUB6EJbYwBnVoHv9JhqyioHR21p6N2GNRQ7ekoPvimxwP9coX25DqiGeaPh_nwM248BhWNx8YMPAKaTtnW_3PhD7Pxc_E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79565884</pqid></control><display><type>article</type><title>Readability of Over-the-Counter Medication Labels</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Sansgiry, Sujit S. ; Cady, Paul S. ; Patil, Shubhada</creator><creatorcontrib>Sansgiry, Sujit S. ; Cady, Paul S. ; Patil, Shubhada</creatorcontrib><description>This study evaluated information on over-the-counter (OTC) medication labels. Brand-name OTC products were examined to determine compliance with the Label Readability Guidelines recommended by the Nonprescription Drug Manufacturers Association (NOMA). Additionally, the use of pictures on OTC medication labels was assessed. The effect of pictures on other aspects of label design that may affect comprehension was also evaluated. We evaluated 100 OTC medication labels (20 analgesics and 80 cold/cough products). Assessment of label content was based on certain aspects of label design, such as package size, font size of written information, format of information on warnings and indications, use of pictures, and use of advertising claims on product labels. Many products evaluated did not meet NOMA guidelines. Even when font size of product name increased with increase in package size, font size on warnings and indications remained constant at 6 points. Lack of boldface (63%), use of all uppercase font (30%), use of hyphenation (49%), lack of paragraph breaks (19%), and the small font size of 6 points or less (98%) could reduce readability. Packages containing pictures were significantly larger than packages without pictures. Several packages (30%) contained pictures in the indications section. Many products contained advertising claims that were classified as "green" or "quality" (41%) and "free" (38%). Additionally, 43 different advertising claims were identified; some of these may be difficult for patients to interpret. The findings may help FDA develop specific regulations to improve label readability. Pharmacists who recommend OTC products to consumers should be aware of these issues and evaluate requests by consumers regarding OTC drugs accordingly. Acknowledgments: This research was partially supported by the Department of Pharmacy Practice and Administrative Sciences, and by a grant from the Graduate Students Research Committee, Idaho State University.</description><identifier>ISSN: 1086-5802</identifier><identifier>DOI: 10.1016/S1086-5802(16)30244-3</identifier><identifier>PMID: 9479403</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Advertising as Topic ; Drug Labeling - standards ; Evaluation Studies as Topic ; Humans ; Nonprescription Drugs ; United States ; United States Food and Drug Administration</subject><ispartof>Journal of the American Pharmaceutical Association (1996), 1997-09, Vol.37 (5), p.522-528</ispartof><rights>1997 American Pharmacists Association</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2073-e89c2921d1a74ff723a5d1d962dace550a31f215fd1f9558700077004a069a23</citedby><cites>FETCH-LOGICAL-c2073-e89c2921d1a74ff723a5d1d962dace550a31f215fd1f9558700077004a069a23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9479403$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sansgiry, Sujit S.</creatorcontrib><creatorcontrib>Cady, Paul S.</creatorcontrib><creatorcontrib>Patil, Shubhada</creatorcontrib><title>Readability of Over-the-Counter Medication Labels</title><title>Journal of the American Pharmaceutical Association (1996)</title><addtitle>J Am Pharm Assoc (Wash)</addtitle><description>This study evaluated information on over-the-counter (OTC) medication labels. Brand-name OTC products were examined to determine compliance with the Label Readability Guidelines recommended by the Nonprescription Drug Manufacturers Association (NOMA). Additionally, the use of pictures on OTC medication labels was assessed. The effect of pictures on other aspects of label design that may affect comprehension was also evaluated. We evaluated 100 OTC medication labels (20 analgesics and 80 cold/cough products). Assessment of label content was based on certain aspects of label design, such as package size, font size of written information, format of information on warnings and indications, use of pictures, and use of advertising claims on product labels. Many products evaluated did not meet NOMA guidelines. Even when font size of product name increased with increase in package size, font size on warnings and indications remained constant at 6 points. Lack of boldface (63%), use of all uppercase font (30%), use of hyphenation (49%), lack of paragraph breaks (19%), and the small font size of 6 points or less (98%) could reduce readability. Packages containing pictures were significantly larger than packages without pictures. Several packages (30%) contained pictures in the indications section. Many products contained advertising claims that were classified as "green" or "quality" (41%) and "free" (38%). Additionally, 43 different advertising claims were identified; some of these may be difficult for patients to interpret. The findings may help FDA develop specific regulations to improve label readability. Pharmacists who recommend OTC products to consumers should be aware of these issues and evaluate requests by consumers regarding OTC drugs accordingly. Acknowledgments: This research was partially supported by the Department of Pharmacy Practice and Administrative Sciences, and by a grant from the Graduate Students Research Committee, Idaho State University.</description><subject>Advertising as Topic</subject><subject>Drug Labeling - standards</subject><subject>Evaluation Studies as Topic</subject><subject>Humans</subject><subject>Nonprescription Drugs</subject><subject>United States</subject><subject>United States Food and Drug Administration</subject><issn>1086-5802</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1PwzAMhnMAjTH4CZN6QnAoOEnTNieEKr6koUmwe5Qljgjq2pG0k_bv6T60Kxdbtt_Xlh9CphTuKdD84YtCmaeiBHZL8zsOLMtSfkbGp_YFuYzxB4ALysoRGcmskBnwMaGfqK1e-tp326R1yXyDIe2-Ma3avukwJB9ovdGdb5tkppdYxyty7nQd8fqYJ2Tx8ryo3tLZ_PW9epqlhkHBUyylYZJRS3WROVcwroWlVubMaoNCgObUMSqcpU4KURYAUAwh05BLzfiE3BzWrkP722Ps1MpHg3WtG2z7qAopclGW2SAUB6EJbYwBnVoHv9JhqyioHR21p6N2GNRQ7ekoPvimxwP9coX25DqiGeaPh_nwM248BhWNx8YMPAKaTtnW_3PhD7Pxc_E</recordid><startdate>199709</startdate><enddate>199709</enddate><creator>Sansgiry, Sujit S.</creator><creator>Cady, Paul S.</creator><creator>Patil, Shubhada</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199709</creationdate><title>Readability of Over-the-Counter Medication Labels</title><author>Sansgiry, Sujit S. ; Cady, Paul S. ; Patil, Shubhada</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2073-e89c2921d1a74ff723a5d1d962dace550a31f215fd1f9558700077004a069a23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Advertising as Topic</topic><topic>Drug Labeling - standards</topic><topic>Evaluation Studies as Topic</topic><topic>Humans</topic><topic>Nonprescription Drugs</topic><topic>United States</topic><topic>United States Food and Drug Administration</topic><toplevel>online_resources</toplevel><creatorcontrib>Sansgiry, Sujit S.</creatorcontrib><creatorcontrib>Cady, Paul S.</creatorcontrib><creatorcontrib>Patil, Shubhada</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Pharmaceutical Association (1996)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sansgiry, Sujit S.</au><au>Cady, Paul S.</au><au>Patil, Shubhada</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Readability of Over-the-Counter Medication Labels</atitle><jtitle>Journal of the American Pharmaceutical Association (1996)</jtitle><addtitle>J Am Pharm Assoc (Wash)</addtitle><date>1997-09</date><risdate>1997</risdate><volume>37</volume><issue>5</issue><spage>522</spage><epage>528</epage><pages>522-528</pages><issn>1086-5802</issn><abstract>This study evaluated information on over-the-counter (OTC) medication labels. Brand-name OTC products were examined to determine compliance with the Label Readability Guidelines recommended by the Nonprescription Drug Manufacturers Association (NOMA). Additionally, the use of pictures on OTC medication labels was assessed. The effect of pictures on other aspects of label design that may affect comprehension was also evaluated. We evaluated 100 OTC medication labels (20 analgesics and 80 cold/cough products). Assessment of label content was based on certain aspects of label design, such as package size, font size of written information, format of information on warnings and indications, use of pictures, and use of advertising claims on product labels. Many products evaluated did not meet NOMA guidelines. Even when font size of product name increased with increase in package size, font size on warnings and indications remained constant at 6 points. Lack of boldface (63%), use of all uppercase font (30%), use of hyphenation (49%), lack of paragraph breaks (19%), and the small font size of 6 points or less (98%) could reduce readability. Packages containing pictures were significantly larger than packages without pictures. Several packages (30%) contained pictures in the indications section. Many products contained advertising claims that were classified as "green" or "quality" (41%) and "free" (38%). Additionally, 43 different advertising claims were identified; some of these may be difficult for patients to interpret. The findings may help FDA develop specific regulations to improve label readability. Pharmacists who recommend OTC products to consumers should be aware of these issues and evaluate requests by consumers regarding OTC drugs accordingly. Acknowledgments: This research was partially supported by the Department of Pharmacy Practice and Administrative Sciences, and by a grant from the Graduate Students Research Committee, Idaho State University.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>9479403</pmid><doi>10.1016/S1086-5802(16)30244-3</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1086-5802
ispartof Journal of the American Pharmaceutical Association (1996), 1997-09, Vol.37 (5), p.522-528
issn 1086-5802
language eng
recordid cdi_proquest_miscellaneous_79565884
source MEDLINE; Alma/SFX Local Collection
subjects Advertising as Topic
Drug Labeling - standards
Evaluation Studies as Topic
Humans
Nonprescription Drugs
United States
United States Food and Drug Administration
title Readability of Over-the-Counter Medication Labels
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-31T00%3A15%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Readability%20of%20Over-the-Counter%20Medication%20Labels&rft.jtitle=Journal%20of%20the%20American%20Pharmaceutical%20Association%20(1996)&rft.au=Sansgiry,%20Sujit%20S.&rft.date=1997-09&rft.volume=37&rft.issue=5&rft.spage=522&rft.epage=528&rft.pages=522-528&rft.issn=1086-5802&rft_id=info:doi/10.1016/S1086-5802(16)30244-3&rft_dat=%3Cproquest_cross%3E79565884%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79565884&rft_id=info:pmid/9479403&rft_els_id=S1086580216302443&rfr_iscdi=true